Press releases
- Ginkgo Bioworks to Participate in Two Conferences in May
- Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
- Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
- Ginkgo Bioworks Reports First Quarter 2024 Financial Results
- GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
- Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
- Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
- Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
- Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
- Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
More ▼
Key statistics
On Friday, Ginkgo Bioworks Holdings Inc (DNA*:MEX) closed at 19.26, 1.69% above its 52-week low of 18.94, set on Mar 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 9.00 |
Offer | -- |
Previous close | 19.26 |
Average volume | -- |
---|---|
Shares outstanding | 2.21bn |
Free float | 1.59bn |
P/E (TTM) | -- |
Market cap | 1.17bn USD |
EPS (TTM) | -0.4347 USD |
Data delayed at least 20 minutes, as of Mar 22 2024 18:59 BST.
More ▼